Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis - Not always self-limiting, fully reversible or predictable

Mult Scler. 2018 Apr;24(4):552-553. doi: 10.1177/1352458517719151. Epub 2017 Jun 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Multiple Sclerosis*
  • Multiple Sclerosis, Relapsing-Remitting*
  • Thrombocytopenia*

Substances

  • Antibodies, Monoclonal, Humanized
  • Alemtuzumab